Intelicare Hospice Services 441 S Main Street, Suite 4, Standish, MI, 48658 | |
(989) 941-9975 |
News Archive
Cellular and Molecular Gastroenterology and Hepatology is committed to publishing impactful digestive biology research covering a broad spectrum of themes in GI, hepatology and pancreatology. We wanted to share two new CMGH articles, which both offer important insight into future interventions for chronic conditions.
Cloud solutions to accelerate local ICT companies' adoption of technologies and overcome end-user challenges faced by the ICT industry
Vasan Ramachandran, MD, FACC, the Jay and Louise Coffman Professor in Vascular Medicine at Boston University School of Medicine, has been selected as the 2021 recipient of the Louis and Artur Lucian Award, an honor bestowed annually to one researcher from around the world who has made outstanding contributions to the field of circulatory diseases.
Inovio Biomedical Corporation announced today that it achieved positive results from its proprietary research and development program for DNA-based cancer vaccines delivered using the company's electroporation-based DNA delivery technology.
Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.
› Verified 3 days ago
Name | Intelicare Hospice Services |
---|---|
Location | 441 S Main Street, Suite 4, Standish, Michigan |
Hospice ID | 231651 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Partnership |
Profit Type | FOR PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 050 |
News Archive
Cellular and Molecular Gastroenterology and Hepatology is committed to publishing impactful digestive biology research covering a broad spectrum of themes in GI, hepatology and pancreatology. We wanted to share two new CMGH articles, which both offer important insight into future interventions for chronic conditions.
Cloud solutions to accelerate local ICT companies' adoption of technologies and overcome end-user challenges faced by the ICT industry
Vasan Ramachandran, MD, FACC, the Jay and Louise Coffman Professor in Vascular Medicine at Boston University School of Medicine, has been selected as the 2021 recipient of the Louis and Artur Lucian Award, an honor bestowed annually to one researcher from around the world who has made outstanding contributions to the field of circulatory diseases.
Inovio Biomedical Corporation announced today that it achieved positive results from its proprietary research and development program for DNA-based cancer vaccines delivered using the company's electroporation-based DNA delivery technology.
Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.
› Verified 3 days ago
NPI Number | 1053709279 |
Organization Name | Intelicare Hospice Services, Llc |
Address | 441 S Main St Standish, Michigan, 48658 |
Phone Number | (989)846-0480 |
News Archive
Cellular and Molecular Gastroenterology and Hepatology is committed to publishing impactful digestive biology research covering a broad spectrum of themes in GI, hepatology and pancreatology. We wanted to share two new CMGH articles, which both offer important insight into future interventions for chronic conditions.
Cloud solutions to accelerate local ICT companies' adoption of technologies and overcome end-user challenges faced by the ICT industry
Vasan Ramachandran, MD, FACC, the Jay and Louise Coffman Professor in Vascular Medicine at Boston University School of Medicine, has been selected as the 2021 recipient of the Louis and Artur Lucian Award, an honor bestowed annually to one researcher from around the world who has made outstanding contributions to the field of circulatory diseases.
Inovio Biomedical Corporation announced today that it achieved positive results from its proprietary research and development program for DNA-based cancer vaccines delivered using the company's electroporation-based DNA delivery technology.
Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.
› Verified 3 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Cellular and Molecular Gastroenterology and Hepatology is committed to publishing impactful digestive biology research covering a broad spectrum of themes in GI, hepatology and pancreatology. We wanted to share two new CMGH articles, which both offer important insight into future interventions for chronic conditions.
Cloud solutions to accelerate local ICT companies' adoption of technologies and overcome end-user challenges faced by the ICT industry
Vasan Ramachandran, MD, FACC, the Jay and Louise Coffman Professor in Vascular Medicine at Boston University School of Medicine, has been selected as the 2021 recipient of the Louis and Artur Lucian Award, an honor bestowed annually to one researcher from around the world who has made outstanding contributions to the field of circulatory diseases.
Inovio Biomedical Corporation announced today that it achieved positive results from its proprietary research and development program for DNA-based cancer vaccines delivered using the company's electroporation-based DNA delivery technology.
Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.
› Verified 3 days ago
Home Health Aides | 1 |
Counselors | 1 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 1 |
Total Employees | 5 |
---|
News Archive
Cellular and Molecular Gastroenterology and Hepatology is committed to publishing impactful digestive biology research covering a broad spectrum of themes in GI, hepatology and pancreatology. We wanted to share two new CMGH articles, which both offer important insight into future interventions for chronic conditions.
Cloud solutions to accelerate local ICT companies' adoption of technologies and overcome end-user challenges faced by the ICT industry
Vasan Ramachandran, MD, FACC, the Jay and Louise Coffman Professor in Vascular Medicine at Boston University School of Medicine, has been selected as the 2021 recipient of the Louis and Artur Lucian Award, an honor bestowed annually to one researcher from around the world who has made outstanding contributions to the field of circulatory diseases.
Inovio Biomedical Corporation announced today that it achieved positive results from its proprietary research and development program for DNA-based cancer vaccines delivered using the company's electroporation-based DNA delivery technology.
Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.
› Verified 3 days ago
Intelicare Hospice Services Location: 441 S Main Street, Suite 4, Standish, Michigan, 48658 Phone: (989) 941-9975 |